VNOV Revenue Surges 46% on Supplement Sales, Cash Position Strengthens

TL;DR

**VNOV's supplement sales are booming, driving revenue and cash, but watch out for those persistent consulting losses.**

AI Summary

YIJIA GROUP CORP. (VNOV) reported a mixed financial performance for the period ended October 31, 2025. Revenue, net, increased significantly by 46.2% to $427,115 for the three months ended October 31, 2025, compared to $292,118 in the prior year. For the six months, revenue grew 32.5% to $531,014 from $400,595. Gross profit also saw substantial gains, rising 67.4% to $260,803 for the three-month period and 43.9% to $329,584 for the six-month period. However, net income for the six months ended October 31, 2025, was a loss of $10,491, an improvement from the $22,564 net loss in the same period last year. The company's cash position improved substantially, with cash increasing to $1,259,281 as of October 31, 2025, from $782,810 as of April 30, 2025. This was primarily driven by $476,471 in net cash provided by operating activities for the six months, a significant turnaround from the $495,241 used in operating activities in the prior year. The Dietary Supplement Segment is the primary revenue driver, contributing $420,626 of the $427,115 total revenue for the three months ended October 31, 2025, and generating a segment income of $232,129. In contrast, the Consulting Service Segment reported a segment loss of $132,959 for the same three-month period.

Why It Matters

This filing reveals YIJIA GROUP CORP.'s strong revenue growth, primarily fueled by its dietary supplement segment, which is crucial for investors seeking growth opportunities in the health and wellness market. The significant increase in cash from operating activities indicates improved operational efficiency and financial health, potentially reducing reliance on external financing. However, the continued losses in the consulting segment and the overall net loss for the six-month period highlight areas of concern, suggesting that profitability remains a challenge despite top-line growth. Competitively, the company's ability to grow its supplement sales in the U.S. market, where it generated all its revenue for the period, could signal a strong niche, but also a concentration risk.

Risk Assessment

Risk Level: medium — While YIJIA GROUP CORP. shows strong revenue growth and improved cash flow from operations, the company still reported a net loss of $10,491 for the six months ended October 31, 2025. Furthermore, the Consulting Service Segment consistently operates at a loss, with a segment loss of $132,959 for the three months ended October 31, 2025, indicating a drag on overall profitability and potential operational inefficiencies in that segment.

Analyst Insight

Investors should closely monitor YIJIA GROUP CORP.'s ability to achieve sustained profitability, particularly by addressing the losses in its Consulting Service Segment. While the growth in the Dietary Supplement Segment is positive, a deeper dive into the sustainability of this growth and the company's strategy for its underperforming segment is warranted before making significant investment decisions.

Financial Highlights

debt To Equity

0.23

revenue

$427,115

operating Margin

N/A

total Assets

$2,336,244

total Debt

$0

net Income

-$10,491

eps

N/A

gross Margin

61.1%

cash Position

$1,259,281

revenue Growth

+46.2%

Revenue Breakdown

Key Numbers

• $427,115 — Revenue, net (3 months) (Increased 46.2% from $292,118 in prior year)
• $531,014 — Revenue, net (6 months) (Increased 32.5% from $400,595 in prior year)
• $260,803 — Gross profit (3 months) (Increased 67.4% from $155,834 in prior year)
• $10,491 — Net loss (6 months) (Improved from $22,564 net loss in prior year)
• $1,259,281 — Cash (October 31, 2025) (Increased from $782,810 as of April 30, 2025)
• $476,471 — Net cash from operating activities (6 months) (Turnaround from $495,241 used in prior year)
• $420,626 — Dietary supplement product sales (3 months) (Primary revenue driver, contributing to 98.5% of total revenue)
• $132,959 — Consulting Service Segment loss (3 months) (Indicates ongoing unprofitability in this segment)

Key Players & Entities

• YIJIA GROUP CORP. (company) — registrant
• NutriPeak Trading Corporation (company) — subsidiary of YIJIA GROUP CORP.
• SEC (regulator) — Securities and Exchange Commission
• $427,115 (dollar_amount) — revenue for three months ended October 31, 2025
• $531,014 (dollar_amount) — revenue for six months ended October 31, 2025
• $1,259,281 (dollar_amount) — cash as of October 31, 2025
• $10,491 (dollar_amount) — net loss for six months ended October 31, 2025
• $232,129 (dollar_amount) — Dietary Supplement Segment income for three months ended October 31, 2025
• $132,959 (dollar_amount) — Consulting Service Segment loss for three months ended October 31, 2025

FAQ

Risk Factors

• Dependence on Dietary Supplement Segment [high — operational]: The Company's revenue is heavily reliant on its Dietary Supplement Segment, which accounted for 98.5% of total revenue in the three months ended October 31, 2025 ($420,626 out of $427,115). A significant downturn in this segment could materially impact the Company's financial performance and ability to generate profits.
• Consulting Service Segment Unprofitability [medium — financial]: The Consulting Service Segment reported a loss of $132,959 for the three months ended October 31, 2025. This ongoing unprofitability in a segment, even if smaller, drains resources and could negatively affect overall financial health if not addressed.
• Dietary Supplement Regulations [medium — regulatory]: The Company operates in the dietary supplement market, which is subject to various regulations concerning product safety, labeling, and marketing claims. Non-compliance with these regulations could lead to penalties, product recalls, and damage to the Company's reputation.
• Competition in Dietary Supplements [medium — market]: The dietary supplement market is highly competitive, with numerous established players and new entrants. Maintaining market share and profitability requires continuous innovation, effective marketing, and competitive pricing, which can be challenging.

Industry Context

Yijia Group Corp. operates in two distinct sectors: dietary supplements and consulting services. The dietary supplement market is characterized by growing consumer interest in health and wellness, but also by intense competition and evolving regulatory landscapes. The consulting services sector is typically driven by business needs for expertise in management, finance, and accounting, often influenced by economic conditions and corporate strategy.

Regulatory Implications

The company faces regulatory scrutiny primarily within the dietary supplement industry, which involves adherence to standards for product safety, labeling, and marketing claims. Compliance with these regulations is critical to avoid penalties and maintain consumer trust. The consulting services segment is less directly regulated but must adhere to professional standards and business laws.

What Investors Should Do

1. Monitor the profitability of the Consulting Service Segment.
2. Analyze the sustainability of revenue growth in the Dietary Supplement Segment.
3. Evaluate the management of operating expenses.
4. Assess the impact of the improved cash position.

Key Dates

• 2025-10-31: End of Interim Reporting Period — Represents the period for which the unaudited condensed consolidated financial statements are presented, showing significant revenue growth and improved cash position.
• 2025-04-30: Prior Fiscal Year End / Balance Sheet Date — Provides the comparative balance sheet figures, showing an increase in cash from $782,810 to $1,259,281.
• 2024-10-31: Prior Year Interim Reporting Period End — Used for year-over-year comparisons of revenue, gross profit, and net loss, indicating significant revenue growth and a reduced net loss.

Glossary

Revenue, net

The total amount of income generated from sales of goods or services, after deducting returns, allowances, and discounts. (Key indicator of the company's top-line performance and market demand for its products and services.)

Gross profit

The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. (Measures the efficiency of production and direct costs, showing the company's ability to generate profit from its core operations.)

Net loss

The total expenses incurred by a company exceed its total revenues over a specific period. (Indicates the company's overall profitability. An improvement from a prior period loss is a positive sign, even if still in loss.)

Operating activities

Cash generated or used by the normal, day-to-day business operations of a company. (Shows the company's ability to generate cash from its core business, a crucial indicator of financial health and sustainability.)

Segment income

The profit or loss attributable to a specific business segment after deducting direct costs and allocated operating expenses. (Helps assess the profitability of individual business units, highlighting areas of strength and weakness.)

Ex Works (EXW)

An Incoterm where the seller makes the goods available at their premises or another named place, and the buyer bears all costs and risks from that point onwards. (Relevant to the revenue recognition policy for dietary supplement products, indicating when title and risk of loss transfer to the customer.)

Year-Over-Year Comparison

Compared to the prior year's comparable periods, Yijia Group Corp. has demonstrated robust revenue growth, with a 46.2% increase in the three months ended October 31, 2025, reaching $427,115. Gross profit also saw substantial gains, rising 67.4% to $260,803. While the company still incurred a net loss of $10,491 for the six months ended October 31, 2025, this represents an improvement from the $22,564 net loss in the prior year. A significant positive development is the turnaround in operating cash flow, from a use of $495,241 to a generation of $476,471, bolstering the cash position to $1,259,281.

Key Financial Figures

• $1 — 100 shares of common stock, par value $1 per share 100 % YJGJ and its subsid
• $0.05 — l Officer - Steve Niu, at fair value of $0.05 per share, subject to vesting condition

Filing Documents

• yijia_i10q-103125.htm (10-Q) — 711KB
• yijia_ex3101.htm (EX-31.1) — 9KB
• yijia_ex3102.htm (EX-31.2) — 9KB
• yijia_ex3201.htm (EX-32.1) — 3KB
• yijia_ex3202.htm (EX-32.2) — 3KB
• 0001683168-25-009163.txt ( ) — 3864KB
• yjgj-20251031.xsd (EX-101.SCH) — 27KB
• yjgj-20251031_cal.xml (EX-101.CAL) — 37KB
• yjgj-20251031_def.xml (EX-101.DEF) — 70KB
• yjgj-20251031_lab.xml (EX-101.LAB) — 227KB
• yjgj-20251031_pre.xml (EX-101.PRE) — 185KB
• yijia_i10q-103125_htm.xml (XML) — 681KB

Financial Statements

Financial Statements 3 Unaudited Condensed Consolidated Balance Sheets as of October 31, 2025 and April 30, 2025 4 Unaudited Condensed Consolidated Statements of Operations for the Three and Six Months ended October 31, 2025 and 2024 5 Unaudited Condensed Consolidated Statements of Changes in Shareholders' Equity for the Three and Six Months Ended October 31, 2025 and 2024 6 Unaudited Condensed Consolidated Statements of Cash Flows for the Six Months ended October 31, 2025 and 2024 7 Notes to the Unaudited Condensed Consolidated Financial Statements 8 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 20 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 27 Item 4.

Controls and Procedures

Controls and Procedures 27 PART II OTHER INFORMATION: Item 1.

Legal Proceedings

Legal Proceedings 28 Item 1A

Risk Factors

Risk Factors 28 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 28 Item 3. Defaults Upon Senior Securities 28 Item 4. Mine Safety Disclosures 28 Item 5. Other Information 28 Item 6. Exhibits 28

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION ITEM 1.

FINANCIAL STATEMENTS

FINANCIAL STATEMENTS The accompanying interim consolidated financial without audit pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with United States generally accepted principles have been condensed or omitted pursuant to such rules and regulations. The interim consolidated financial statements are condensed and should be read in conjunction with the Company's latest annual consolidated financial statements. In the opinion of management, the consolidated financial statements contain all material adjustments, consisting only of normal adjustments considered necessary to present fairly the financial condition, results of operations, and cash flows of the Company for the interim periods presented. 3 YIJIA GROUP CORP. UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS October 31, 2025 April 30, 2025 (Unaudited) ASSETS Current assets: Cash $ 1,259,281 $ 782,810 Accounts receivable 882,612 1,266,951 Advances to vendors 172,310 158,802 Prepayment 7,333 – Inventories 11,267 44,247 Other current assets 3,441 3,441 Total current assets 2,336,244 2,256,251 TOTAL ASSETS $ 2,336,244 $ 2,256,251 LIABILITIES AND SHAREHOLDERS' EQUITY Current Liabilities: Accrued expenses $ 68,713 $ 60,065 Accounts payable 168,450 – Deferred revenue 4,286 – Other current liabilities 3,951 820 Income tax payable 192,651 286,682 Total current liabilities 438,051 347,567 TOTAL LIABILITIES 438,051 347,567 Commitments and Contingencies – – Shareholders' equity: Common Stock, $ 0.001 par value; 75,000,000 shares authorized; 25,012,270 shares issued and outstanding as of October 31, 2025 and April 30, 2025 25,012 25,012 Additional paid in capital 1,012,971 1,012,971 Shares

FINANCIAL STATEMENTS

FINANCIAL STATEMENTS NOTE 1 – ORGANIZATION AND NATURE OF

BUSINESS

BUSINESS Yijia Group Corp. ("the Company" or "YJGJ") was incorporated on January 25, 2017 under the laws of the State of Nevada, United States of America, formerly known as Soldino Group Corp. The Company has currently commenced its operation in the rendering of consulting advisory services in management business, accounting and finance services; and provides dietary supplement products and health consultation services to domestic and international customers. The details of the Company's subsidiary are described below: Schedule of details of company subsidiary Name Place of incorporation and kind of legal entity Principal activities and place of operation Particulars of issued/ registered share capital Effective interest Held NutriPeak Trading Corporation ("NTC") Marketing and supplying dietary supplement products 100 shares of common stock, par value $1 per share 100 % YJGJ and its subsidiary are hereinafter referred to as the "Company". NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared by management in accordance with both accounting principles generally accepted in the United States ("GAAP"), and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Certain information and note disclosures normally included in audited consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. The unaudited condensed consolidated financial statements are presented in US dollars, which is the Company's functional currency. In the opinion of management, the condensed balance sheet as of April 30, 2025 which has been derived from audited consolidated fi

financial statements and accompanying notes. Actual results could differ from those estimates

financial statements and accompanying notes. Actual results could differ from those estimates. Significant areas for which management uses estimates include: sales returns at point in time and allowances; inventory; income tax valuation allowances These estimates require the use of judgment as future events, and the effect of these events cannot be predicted with certainty. The estimates will change as new events occur, as more experience is acquired and as more information is obtained. We evaluate and update our assumptions and estimates on an ongoing basis and we may consult outside experts to assist as considered necessary. Revenue Recognition identify the contract with a customer; identify the performance obligations in the contract; determine the transaction price; allocate the transaction price to performance obligations in the contract; and recognize revenue as the performance obligation is satisfied. Currently, the Company operates in two business segments. The Consulting Service Segment mainly provides consulting advisory services in management, business, accounting and finance; and the dietary supplement products and health consultation services to customers. The sale and distribution of dietary supplement products, such as Nicotinamide Riboside capsules, has only one performance obligation under the fixed-fee arrangements. Revenue is recognized from the sale of their dietary supplement products upon delivery to the customers, whereas the title and risk of loss are fully transferred to customers. Shipping term under Ex Works ("EXW"), the Company fulfills the obligation to deliver when the products are available on their premises, i.e. the warehouse. Customers are responsible for all transportation costs, risk of loss, and any other costs that point onward. Revenue is earned from the rendering of consulting advisory services to customers. The Company recognizes services revenue over the period in which such services are performed an

View Full Filing

View this 10-Q filing on SEC EDGAR